Asia Deal Watch: Takeda Will Employ Engitix’s ECM Tech In Liver Fibrosis Indications
SCRIP – View full story (behind a paywall)
Entries by Editor
EASL – The European Association for the Study of the Liver – International Liver Congress
15-19 April 2020 EASL – The European Association for the Study of the Liver – International Liver Congress London, UK Team members attending: Dr Giuseppe Mazza, CEO, Dr Gino Van Heeke, CSO and Engitix scientists
LSX World Congress
4-5 February 2020 LSX World Congress London, UK Team members attending: Dr Giuseppe Mazza, CEO [panel speaker]
Biotech Showcase / J.P. Morgan Healthcare Conference
13-16 January 2020 Biotech Showcase / J.P. Morgan Healthcare Conference San Francisco, USA Team members attending: Dr Giuseppe Mazza, CEO, David Dally, CFO
Cirrhotic Human Liver Extracellular Matrix 3D Scaffolds Promote Smad-Dependent TGF-β1 Epithelial Mesenchymal Transition
January 2020 Cirrhotic Human Liver Extracellular Matrix 3D Scaffolds Promote Smad-Dependent TGF-β1 Epithelial Mesenchymal Transition Mazza. G, Telese. A, Al-Akkad. W, Frenguelli. L, Levi. A, Marrali. M, Longato. L, Thanapirom. K, Vilia. M.G, Lombardi. B, Crowley. C, Crawford. M, Karsdal. M.A, Leeming. D.J, Marrone. G, Bottcher. K, Robinson. B, Del Rio Hernandez. A, Tamburrino. D, […]
Engitix and Morphic Enter Research Collaboration to Identify ECM-related Targets in Fibrostenotic Inflammatory Bowel Disease (IBD)
London, UK and Waltham, Massachusetts, USA – 10 December, 2019 – Engitix Ltd (‘Engitix’), a biotechnology company developing a portfolio of programmes in fibrosis and solid tumours using its proprietary human extracellular matrix (ECM) platform, and Morphic Therapeutic (‘Morphic’), a biopharmaceutical company developing oral integrin therapies, today announce that they have entered into a research […]
Jefferies 2019 London Healthcare Conference
20-21 November 2019 Jefferies 2019 London Healthcare Conference London, UK Team members attending: Dr Giuseppe Mazza, CEO, David Dally, CFO, Stephen Brindle, COO
70th Annual Meeting of the American Association for The Study of Liver Diseases
8-12 November 2019 70th Annual Meeting of the American Association for The Study of Liver Diseases (AASLD) Boston, USA Team members attending: Dr Giuseppe Mazza, CEO, Dr Gino Van Heeke, CSO, Massimo Pinzani
Engitix Receives a Golden Ticket to LabCentral from Takeda to Advance Fibrosis and Solid Tumour Research
Golden Ticket includes one year of lab bench space at Cambridge, MA-based shared laboratory and office space London, UK, 5 November 2019 – Engitix Ltd (‘Engitix’), a private company focused on drug discovery for fibrosis and solid tumours based on its pioneering human extracellular matrix (ECM) platform, announced that its subsidiary Engitix, Inc, has been awarded a Golden Ticket […]
